Evidence map›Paper›PMID 42415733›Full record

ArticleOpen forum infectious diseases2026

Respiratory Pathogen Detection Among Febrile Inpatients in Northern Tanzania, 2016-2019.

Martin Linster, Marina Zahari, Yan Zhuang, Marcus G Mah, Manuela Carugati, Ganga Moorthy, Deng B Madut, Michael J Maze, Bingileki Lwezaula, Annette Marandu and 11 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Martin LinsterProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.ORCID https://orcid.org/0000-0003-2636-2512
Marina ZahariSaw Swee Hock School of Public Health, National University of Singapore, Singapore.ORCID https://orcid.org/0000-0002-1451-6628
Yan ZhuangProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.ORCID https://orcid.org/0000-0002-1525-8974
Marcus G MahProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.ORCID https://orcid.org/0000-0001-8861-7328
Manuela CarugatiDivision of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0002-3187-5905
Ganga MoorthyDivision of Pediatric Infectious Diseases, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0003-3191-1117
Deng B MadutDivision of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0003-4023-3928
Michael J MazeDepartment of Medicine, University of Otago, Christchurch, New Zealand.ORCID https://orcid.org/0000-0001-8909-1508
Bingileki LwezaulaMawenzi Regional Referral Hospital, Moshi, Tanzania.ORCID https://orcid.org/0000-0003-2909-9705
Annette MaranduMawenzi Regional Referral Hospital, Moshi, Tanzania.ORCID https://orcid.org/0000-0002-3501-9591
Calvin MachareMawenzi Regional Referral Hospital, Moshi, Tanzania.
Kajiru G KilonzoKilimanjaro Christian Medical Centre, Moshi, Tanzania.ORCID https://orcid.org/0000-0002-0367-5826
Ronald MbwasiKilimanjaro Christian Medical Centre, Moshi, Tanzania.ORCID https://orcid.org/0000-0002-2365-5072
Blandina T MmbagaKilimanjaro Christian Medical Centre, Moshi, Tanzania.ORCID https://orcid.org/0000-0002-5550-1916
James S NgochoKilimanjaro Christian Medical Centre, Moshi, Tanzania.ORCID https://orcid.org/0000-0001-6242-9863
John P BonnewellDivision of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0002-2886-4885
Lin-Fa WangProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.ORCID https://orcid.org/0000-0003-2752-0535
John A CrumpDivision of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0002-4529-102X
Venance P MaroKilimanjaro Christian Medical Centre, Moshi, Tanzania.ORCID https://orcid.org/0000-0003-3838-0312
Gavin J D SmithProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.ORCID https://orcid.org/0000-0001-5031-468X
Matthew P RubachProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.ORCID https://orcid.org/0000-0001-5262-1421

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
Investigating Febrile Deaths in Tanzania (INDITe)R01AI121378 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2016 to 2020
$2.7M
Viral Zoonoses and Severe Febrile Illness in Northern TanzaniaK23AI116869 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2016 to 2020
$896k
NIAID NIH HHS K23 AI116869NIAID NIH HHS P30 AI064518NIAID NIH HHS R01 AI121378
6 · The paper itself

Abstract

Background: Febrile illness is a common reason for hospital admission in sub-Saharan Africa, yet the illness etiology often remains unknown. To address these knowledge gaps, we conducted respiratory pathogen testing in a cohort of febrile inpatients in northern Tanzania. Methods: We enrolled a prospective cohort of febrile pediatric and adult inpatients within 24 hours after admission to 2 hospitals in northern Tanzania. Nasopharyngeal/oropharyngeal specimens were collected for detection of 19 pathogens with polymerase chain reaction. Participants were stratified by age (<10 or and ≥10 years) and categorized into the following 3 groups: severe acute respiratory infection (SARI), non-SARI respiratory illness, or no respiratory illness. Results: Among the 1132 participants enrolled, 930 (82.1%) had nasopharyngeal/oropharyngeal specimens tested. Their median (interquartile range) age was 22.3 (2.1-44.0) years, 432 (46.5%) were female, and 378 (40.7%) had SARIs. We observed 410 pathogen detections in 359 participants (38.6%), in 256 (67.2%) of 381 in the <10-year age group and 103 (18.8%) of 549 in the older group (≥10 years old). Of the 301 pathogen detections among participants <10 years old, the most common were rhinovirus (RV)/enterovirus (EV) (n = 80 [26.6%]), influenza (n = 60 [19.9%]) and adenovirus (n = 45 [15.0%]). Of the 109 pathogen detections in participants ≥10 years old, the most common were RV/EV (n = 41 [37.6%]), influenza (n = 37 [33.9%]), and respiratory syncytial virus (RSV) (n = 6 [5.5%]). Among SARIs, the most common pathogens were influenza (n = 71 [18.8%]), RV/EV (n = 66 [17.5%]), and RSV (n = 37 [9.8%]). Conclusions: RV/EV, influenza and RSV were commonly detected among febrile inpatients in Tanzania, including in participants with SARIs. These findings have implications for vaccine development and implementation in low- and middle-income countries.

Indexed as

feverhospitalizationpathogenrespiratory infectionTanzania

Identifiers

PMID42415733
PMCPMC13338775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.